Article
Steroid is safe for treating conjunctivitis
Loteprednol etabonate ophthalmic suspension 0.2% (Alrex, Bausch & Lomb Pharmaceuticals and Pharmos Corp.), the so-called "safe steroid" approved for treatment of seasonal allergic conjunctivitis, appears to be living up to its billing, according to several ophthalmologists who prescribe the drug for a range of ophthalmic allergies.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Related Videos
Related Content
